Fragment-based and classical quantitative structure–activity relationships for a series of hydrazides as antituberculosis agents

Worldwide, tuberculosis (TB) is the leading cause of death among curable infectious diseases. Multidrug-resistant Mycobacterium tuberculosis is an emerging problem of great importance to public health, and there is an urgent need for new anti-TB drugs. In the present work, classical 2D quantitative structure–activity relationships (QSAR) and hologram QSAR (HQSAR) studies were performed on a training set of 91 isoniazid derivatives. Significant statistical models (classical QSAR, q2 = 0.68 and r2 = 0.72; HQSAR, q2 = 0.63 and r2  =  0.86) were obtained, indicating their consistency for untested compounds. The models were then used to evaluate an external test set containing 24 compounds which were not included in the training set, and the predicted values were in good agreement with the experimental results (HQSAR, $${r^{2}_{pred} = 0.87}$$ ; classical QSAR, $${r^{2}_{pred} = 0.75}$$).

[1]  R. Yunes,et al.  Structure-activity relationships for a collection of structurally diverse inhibitors of purine nucleoside phosphorylase. , 2001, Chemical & pharmaceutical bulletin.

[2]  W. A. Lott,et al.  Chemotherapy of experimental tuberculosis. VII. Heterocyclic acid hydrazides and derivatives. , 1953, American review of tuberculosis.

[3]  Emilio Benfenati,et al.  Virtual screening for aryl hydrocarbon receptor binding prediction. , 2006, Journal of medicinal chemistry.

[4]  W. A. Lott,et al.  Chemotherapy of experimental tuberculosis. VI. Derivatives of isoniazid. , 1953, American review of tuberculosis.

[5]  R. Yunes,et al.  Structure-activity relationships for the analgesic activity of gallic acid derivatives. , 2000, Farmaco.

[6]  Glaucius Oliva,et al.  Two- and three-dimensional quantitative structure-activity relationships for a series of purine nucleoside phosphorylase inhibitors. , 2006, Bioorganic & medicinal chemistry.

[7]  Jorge Gálvez,et al.  Charge Indexes. New Topological Descriptors , 1994, J. Chem. Inf. Comput. Sci..

[8]  G. Klopman,et al.  Computer-aided study of the relationship between structure and antituberculosis activity of a series of isoniazid derivatives , 1996 .

[9]  Carlos A. Montanari,et al.  Structural Basis for Selective Inhibition of Trypanosomatid Glyceraldehyde‐3‐Phosphate Dehydrogenase: Molecular Docking and 3D QSAR Studies. , 2008 .

[10]  G. Oliva,et al.  Virtual screening and its integration with modern drug design technologies. , 2008, Current medicinal chemistry.

[11]  Ying Zhang,et al.  The magic bullets and tuberculosis drug targets. , 2005, Annual review of pharmacology and toxicology.

[12]  A. Andricopulo,et al.  Structure-activity relationships for the design of small-molecule inhibitors. , 2005, Mini reviews in medicinal chemistry.

[13]  Kwang S. Kim,et al.  Homology modeling and molecular dynamics study of chorismate synthase from Shigella flexneri. , 2006, Journal of molecular graphics & modelling.

[14]  Adriano D Andricopulo,et al.  Hologram quantitative structure-activity relationships for a series of farnesoid X receptor activators. , 2005, Bioorganic & medicinal chemistry letters.

[15]  V. Farutin,et al.  Structure-activity relationships for a class of inhibitors of purine nucleoside phosphorylase. , 1999, Journal of medicinal chemistry.

[16]  Ovidiu Ivanciuc,et al.  Design of Topological Indices. Part 10.1 Parameters Based on Electronegativity and Covalent Radius for the Computation of Molecular Graph Descriptors for Heteroatom-Containing Molecules , 1998, J. Chem. Inf. Comput. Sci..

[17]  Marcelo Santos Castilho,et al.  Classical and Hologram QSAR Studies on a Series of Tacrine Derivatives as Butyrylcholinesterase Inhibitors , 2007 .

[18]  G. W. Raiziss,et al.  Chemotherapy of Experimental Tuberculosis. , 1941 .

[19]  Pam Sonnenberg,et al.  How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. , 2005, The Journal of infectious diseases.

[20]  R. L. Stehle,et al.  CHEMOTHERAPY IN EXPERIMENTAL TUBERCULOSIS , 1944 .

[21]  Ramón García-Domenech,et al.  Topological approach to analgesia. , 1994, Journal of chemical information and computer sciences.

[22]  C. Vilchèze,et al.  Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid , 2006, Nature Medicine.

[23]  C. Vilchèze,et al.  Altered NADH/NAD+ Ratio Mediates Coresistance to Isoniazid and Ethionamide in Mycobacteria , 2005, Antimicrobial Agents and Chemotherapy.

[24]  John L. Johnson,et al.  Recent advances in the diagnosis and management of tuberculosis , 2005, Current opinion in pulmonary medicine.

[25]  A. Tropsha,et al.  Beware of q2! , 2002, Journal of molecular graphics & modelling.

[26]  Anderson Coser Gaudio,et al.  BuildQSAR: A New Computer Program for QSAR Analysis , 2000 .

[27]  Subhash C. Basak,et al.  Topological Indices: Their Nature and Mutual Relatedness , 2000, J. Chem. Inf. Comput. Sci..

[28]  Julio Caballero,et al.  Genetic neural network modeling of the selective inhibition of the intermediate-conductance Ca2+-activated K+ channel by some triarylmethanes using topological charge indexes descriptors , 2005, J. Comput. Aided Mol. Des..

[29]  Yu Chen,et al.  Evaluation of Quantitative Structure-Activity Relationship Methods for Large-Scale Prediction of Chemicals Binding to the Estrogen Receptor , 1998, J. Chem. Inf. Comput. Sci..

[30]  P. Small,et al.  Clinical management of tuberculosis in the context of HIV infection. , 2004, Annual review of medicine.

[31]  Adriano D Andricopulo,et al.  Structural and chemical basis for enhanced affinity and potency for a large series of estrogen receptor ligands: 2D and 3D QSAR studies. , 2007, Journal of molecular graphics & modelling.

[32]  A. Andricopulo,et al.  2D Quantitative structure-activity relationship studies on a series of cholesteryl ester transfer protein inhibitors. , 2007, Bioorganic & medicinal chemistry.